Pediatric Antidepressant Safety: “Jury Is Still Out,” FDA Tells Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
Discussion of regulatory status of antidepressant indications is almost an afterthought during Sept. 9 House hearing. FDA’s Woodcock, however, stresses that agency is not ready to rule out a role for antidepressants in children.